We suggest that SERPINH1/HSP47 is also an attractive and ideal target for EMT blocking therapy in VHL‐WT ccRCC because it exhibits the role of driver gene in this study and is specifically expressed in collagen‐producing cells 35. The gene discussed is VHL; the disease is nonpapillary renal cell carcinoma.